Doctor profile · Federal record
Dr. Babak Roshdieh, M.D.
Dermatology Physician (CMS: Dermatology) · Corona, CA
- NPI 1275589723
- Accepts Medicare
- MIPS 77.9 / 100 · 2023
- 30 yrs in practice
- Male
- Solo practice
- No sanctions
Practice & contact
- Primary practice
-
770 Magnolia Ave, Suite 2G
Corona, CA 928793120
(951) 734-6500
fax (951) 734-6555
Credentials & registration
- NPI registered
- May 2006 — 20 yrs on file
- Profile last updated
- November 14, 2014
- Year of graduation
- 1996 — 30 yrs since
- Specialty taxonomy
- 207N00000X — NUCC code
- State license (1)
- California #A76333
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1275589723. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
2,811
Distinct HCPCS
10
Medicare allowed
$204,145
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 1,022 | 168 | $7 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 326 | 257 | $95 | |
17000 |
Destruction of precancer skin growth, 1 growth | 275 | 226 | $55 | |
11102 |
Biopsy of related skin growth, first growth | 256 | 211 | $101 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 187 | 155 | $136 | |
17110 |
Destruction of skin growth, 1-14 growths | 159 | 134 | $121 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 129 | 129 | $119 | |
17004 |
Destruction of precancer skin growth, 15 or more growths | 111 | 90 | $186 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 105 | 89 | $60 | |
11103 |
Biopsy of related skin growth, each additional growth | 57 | 40 | $56 |
In context: peer comparison
Among 2 peers in Corona Dermatology Physician, average services per provider: 159. This provider delivers 18× the peer median.Open Payments
Industry payments received
All-time total
$3,291
Transactions
158
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Abbvie INC. | 41 | $591.05 | |
| Genzyme Corporation | 11 | $286.37 | |
| Novartis Pharmaceuticals Corporation | 14 | $257.32 | |
| Dermavant Sciences, INC. | 13 | $239.46 | |
| Ucb, INC. | 8 | $230.97 | |
| Incyte Corporation | 12 | $221.74 | |
| Janssen Biotech, INC. | 6 | $206.35 | |
| Regeneron Healthcare Solutions, INC. | 8 | $176.15 | |
| Arcutis Biotherapeutics, INC. | 11 | $174.51 | |
| Leo Pharma INC. | 7 | $161.82 | |
| E.R. Squibb & Sons, L.L.C. | 6 | $154.67 | |
| Pfizer INC. | 9 | $138.16 | |
| Lilly USA, LLC | 4 | $95.90 | |
| Galderma Laboratories, L.P. | 5 | $88.99 | |
| Amgen INC. | 3 | $71.69 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,216
Patients
651
Total drug cost
$175,323
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Ketoconazole | Generic | 242 | 125 | $6,934 |
| Triamcinolone Acetonide | Generic | 235 | 144 | $3,761 |
| Hydrocortisone | Generic | 193 | 120 | $2,377 |
| Fluocinonide | Generic | 109 | 51 | $4,888 |
| Clobetasol Propionate | Generic | 55 | 38 | $2,925 |
| Betamethasone Dipropionate | Generic | 53 | 30 | $3,019 |
| Clindamycin Phosphate | Generic | 53 | 19 | $1,981 |
| Doxycycline Hyclate | Generic | 49 | 23 | $2,768 |
| Mupirocin | Generic | 43 | 31 | $383 |
| Fluorouracil | Generic | 41 | 32 | $3,133 |
Frequently asked questions
What is Dr. Babak Roshdieh's medical specialty?
Dr. Babak Roshdieh practices Dermatology Physician in Corona, CA.
Where does Dr. Babak Roshdieh practice?
Dr. Babak Roshdieh practices at 770 Magnolia Ave, Corona, CA 928793120. Office phone: 9517346500.
What is Dr. Babak Roshdieh's NPI?
Dr. Babak Roshdieh's National Provider Identifier (NPI) is 1275589723, issued by NPPES.
Does Dr. Babak Roshdieh accept Medicare assignment?
Yes. Dr. Babak Roshdieh accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Babak Roshdieh commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213); Destruction of precancer skin growth, 1 growth (HCPCS 17000). Source: CMS Medicare Physician & Other Practitioners file.